FFCP PHASE1:Mm9::chr18:74109002..74109010,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=6|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr18:74109002..74109010,+|id=chr18:74109002..74109010,+|ontology_enrichment_celltype=CL:0000049!1.63e-09!19;CL:0000557!2.67e-07!7|ontology_enrichment_celltype_v019_2=CL:0000355,1.66e-10,9|ontology_enrichment_disease=DOID:0060100!3.99e-17!3;DOID:4045!3.99e-17!3;DOID:0050686!7.98e-09!6|ontology_enrichment_disease_v019_2=DOID:0060100,4.54e-30,3;DOID:4045,4.54e-30,3;DOID:0050686,2.00e-15,6|ontology_enrichment_uberon=|ontology_enrichment_uberon_v019_2=UBERON:0001134,1.66e-10,9;UBERON:0002036,1.66e-10,9;UBERON:0002385,1.66e-10,9;UBERON:0000486,1.66e-10,9;UBERON:0007503,1.66e-10,9;UBERON:0001015,1.66e-10,9;UBERON:0002329,1.66e-10,9;UBERON:0003082,1.66e-10,9;UBERON:0003059,1.66e-10,9;UBERON:0007282,1.66e-10,9;UBERON:0004290,1.66e-10,9;UBERON:0009618,1.66e-10,9;UBERON:0000383,1.62e-09,10;UBERON:0007524,1.05e-08,11;UBERON:0003077,1.05e-08,11;UBERON:0007285,1.05e-08,11;UBERON:0002204,1.00e-07,32|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23.4377713212668,36.7227611926186,23.0350447348471,87.6464917166211,43.0318655523821,10.6812277666854,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.479260498023681,1.79970819298022,0.762421362438388,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.1066395619397,1.02939162845886,0.568326998791185,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.25462585178142,0,0.162135226775035,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.279902904647316,0.276399947608848,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.233931608445408,0,0,0,0|short_description=p@chr18:74109002..74109010,+}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=6 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr18:74109002..74109010,+ | |||
|description=CAGE_peak_at_chr18:74109002..74109010,+ | |||
|id=chr18:74109002..74109010,+ | |||
|ontology_enrichment_celltype=CL:0000049!1.63e-09!19;CL:0000557!2.67e-07!7 | |||
|ontology_enrichment_celltype_v019_2=CL:0000355,1.66e-10,9 | |||
|ontology_enrichment_disease=DOID:0060100!3.99e-17!3;DOID:4045!3.99e-17!3;DOID:0050686!7.98e-09!6 | |||
|ontology_enrichment_disease_v019_2=DOID:0060100,4.54e-30,3;DOID:4045,4.54e-30,3;DOID:0050686,2.00e-15,6 | |||
|ontology_enrichment_uberon= | |||
|ontology_enrichment_uberon_v019_2=UBERON:0001134,1.66e-10,9;UBERON:0002036,1.66e-10,9;UBERON:0002385,1.66e-10,9;UBERON:0000486,1.66e-10,9;UBERON:0007503,1.66e-10,9;UBERON:0001015,1.66e-10,9;UBERON:0002329,1.66e-10,9;UBERON:0003082,1.66e-10,9;UBERON:0003059,1.66e-10,9;UBERON:0007282,1.66e-10,9;UBERON:0004290,1.66e-10,9;UBERON:0009618,1.66e-10,9;UBERON:0000383,1.62e-09,10;UBERON:0007524,1.05e-08,11;UBERON:0003077,1.05e-08,11;UBERON:0007285,1.05e-08,11;UBERON:0002204,1.00e-07,32 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23.4377713212668,36.7227611926186,23.0350447348471,87.6464917166211,43.0318655523821,10.6812277666854,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.479260498023681,1.79970819298022,0.762421362438388,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.1066395619397,1.02939162845886,0.568326998791185,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.25462585178142,0,0.162135226775035,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.279902904647316,0.276399947608848,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.233931608445408,0,0,0,0 | |||
|short_description=p@chr18:74109002..74109010,+ | |||
}} |
Latest revision as of 02:52, 6 August 2015
Short description: | p@chr18:74109002..74109010, + |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr18:74109002..74109010, + |
Coexpression cluster: | MCL_coexpression_mm9:6 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
multi-potent skeletal muscle stem cell | 1.66e-10 | 9 |
Ontology term | p-value | n |
---|---|---|
skeletal muscle tissue | 1.66e-10 | 9 |
striated muscle tissue | 1.66e-10 | 9 |
muscle tissue | 1.66e-10 | 9 |
multilaminar epithelium | 1.66e-10 | 9 |
epithelial vesicle | 1.66e-10 | 9 |
musculature | 1.66e-10 | 9 |
somite | 1.66e-10 | 9 |
myotome | 1.66e-10 | 9 |
presomitic mesoderm | 1.66e-10 | 9 |
presumptive segmental plate | 1.66e-10 | 9 |
dermomyotome | 1.66e-10 | 9 |
trunk paraxial mesoderm | 1.66e-10 | 9 |
musculature of body | 1.62e-09 | 10 |
dense mesenchyme tissue | 1.05e-08 | 11 |
paraxial mesoderm | 1.05e-08 | 11 |
presumptive paraxial mesoderm | 1.05e-08 | 11 |
musculoskeletal system | 1.00e-07 | 32 |
Ontology term | p-value | n |
---|---|---|
musculoskeletal system cancer | 4.54e-30 | 3 |
muscle cancer | 4.54e-30 | 3 |
organ system cancer | 2.00e-15 | 6 |